Education
About Us
Working with TipRanks
Follow Us
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Comparison Results
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$25.08
HK$10.14B
69.61
236.19%
0 Buy
0 Hold
0 Sell
Hold
Ascletis Pharma, Inc.
HK$9.52
HK$10.49B
―
605.19%
1 Buy
1 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$7.15
HK$13.44B
―
110.29%
0 Buy
0 Hold
0 Sell
Hold
Keymed Biosciences, Inc.
HK$70.45
HK$20.00B
―
67.54%
1 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$18.04
HK$11.15B
―
279.79%
0 Buy
0 Hold
0 Sell
Moderate Sell
Shandong Boan Biotechnology Company., Limited. Class H
HK$12.03
HK$7.65B
194.66
21.52%
―
Performance Comparison
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
25.08
17.92
250.28%
HK:1672
Ascletis Pharma, Inc.
9.52
8.22
632.31%
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.15
4.07
132.14%
HK:2162
Keymed Biosciences, Inc.
70.45
29.45
71.83%
HK:2171
CARsgen Therapeutics Holdings Ltd.
18.04
13.80
325.47%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
12.03
2.52
26.50%